The pharmaceutical industry relies heavily on specialized intermediates to produce life-saving medications. Among these, 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione, identified by CAS number 666816-98-4, holds significant importance as a key intermediate in the synthesis of Linagliptin, a drug crucial for managing type 2 diabetes. NINGBO INNO PHARMCHEM CO.,LTD., a prominent pharmaceutical intermediates manufacturer in China, offers its expertise on this vital compound.

Our company specializes in high purity chemical synthesis, ensuring that the 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione we supply meets the demanding ≥99.0% purity standard. This high level of purity is critical for the success of complex pharmaceutical syntheses, including that of Linagliptin. By offering this compound, we support drug manufacturers in achieving the desired quality and efficacy in their final products.

When companies seek to buy 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione, they look for reliable partners. As a leading linagliptin intermediate supplier China, NINGBO INNO PHARMCHEM CO.,LTD. provides a seamless sourcing experience. We understand the importance of timely delivery and competitive CAS 666816-98-4 price, ensuring our clients can maintain their production schedules and budgets effectively. Our commitment is to provide superior chemical solutions.

The handling of this intermediate requires adherence to safety standards, given its classification under UN3261 (Class II hazard). NINGBO INNO PHARMCHEM CO.,LTD. prioritizes safety in all its operations, from manufacturing to packaging and shipping. This meticulous approach ensures that the product reaches our clients in optimal condition, ready for use in their advanced synthesis processes.

In conclusion, 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione is a cornerstone intermediate for Linagliptin production. NINGBO INNO PHARMCHEM CO.,LTD. stands as a trusted pharmaceutical intermediates manufacturer, offering expertise, quality, and reliability to the global pharmaceutical industry.